Fracture Risk Down With Osteoporosis Drug in Metastatic Prostate Cancer

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

Fracture Risk Down With Osteoporosis Drug in Metastatic Prostate Cancer (Medage today) – Fractures associated with androgens’ deprivation of deprivation (ADT) for metastatic prostate cancer have significantly decreased in men who have received a bisphosphonate in addition to the norm of care (SOC), the data of a large randomized trial …

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button